King of Prussia’s CluePoints unveiled its latest innovation, reports Timothy Alexander for MSN. Medical & Safety Review (MSR) ...

CluePoints has announced the launch of its latest application, Medical & Safety Review (MSR), designed to revolutionize the ...

Galderma today announced that it will present new data from the ARCADIA and OLYMPIA clinical trial programs investigating ...

BUFFALO, NY / ACCESSWIRE / September 27, 2024 / POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical company, ...

No new safety concerns and consistent safety profiles were observed for long-term risankizumab use in patients with psoriasis and PsA.

Italy: A recent analysis of the FDA Adverse Event Reporting System (FAERS) database has provided new insights into the safety ...

In September 2024, the U.S. Food and Drug Administration (FDA) issued three guidance documents to support different clinical ...

Riociguat is generally safe and effective for PAH patients with coexisting cardiac and metabolic conditions, a trials ...

FDA has lifted the clinical hold on Biomea Fusion's BMF-219 trials for type 1 and type 2 diabetes following a safety review, ...

Cassava's financial challenges and data integrity concerns remain critical. Learn why SAVA stock is rated a strong sell given ...

A meta-analysis reveals gamified digital mental health interventions effectively reduce depression and ADHD in youth, ...

Sanofi has shared data from the phase 3 HERCULES trial that could rescue its multiple sclerosis (MS) drug candidate ...